Show simple item record

dc.contributor.authorPanatto, D
dc.contributor.authorDomnich, A
dc.contributor.authorGasparini, R
dc.contributor.authorBonanni, P
dc.contributor.authorIcardi, G
dc.contributor.authorAmicizia, D
dc.contributor.authorArata, L
dc.contributor.authorBragazzi, NL
dc.contributor.authorSignori, A
dc.contributor.authorLanda, P
dc.contributor.authorBechini, A
dc.contributor.authorBoccalini, S
dc.date.accessioned2016-11-09T13:58:35Z
dc.date.issued2016-01-21
dc.description.abstractGiven the growing use and great potential of mobile apps, this project aimed to develop and implement a user-friendly app to increase laypeople's knowledge and awareness of invasive pneumococcal disease (IPD). Despite the heavy burden of IPD, the documented low awareness of IPD among both laypeople and healthcare professionals and far from optimal pneumococcal vaccination coverage, no app specifically targeting IPD has been developed so far. The app was designed to be maximally functional and conceived in accordance with user-centered design. Its content, layout and usability were discussed and formally tested during several workshops that involved the principal stakeholders, including experts in IPD and information technology and potential end-users. Following several workshops, it was decided that, in order to make the app more interactive, its core should be a personal “checker” of the risk of contracting IPD and a user-friendly risk-communication strategy. The checker was populated with risk factors identified through both Italian and international official guidelines. Formal evaluation of the app revealed its good readability and usability properties. A sister web site with the same content was created to achieve higher population exposure. Seven months after being launched in a price- and registration-free modality, the app, named “Pneumo Rischio,” averaged 20.9 new users/day and 1.3 sessions/user. The first in-field results suggest that “Pneumo Rischio” is a promising tool for increasing the population's awareness of IPD and its prevention through a user-friendly risk checker.en_GB
dc.description.sponsorshipThe development of the app is a part of the project on increasing the population's awareness of invasive pneumococcal disease and has been supported by sponsorship from Pfizer S.r.l. The sponsor had no role in the app design and development. The authors thank Progetti di Impresa Srl for creating the app and website.en_GB
dc.identifier.citationVol. 12, Iss. 4, pp. 1080 - 1084en_GB
dc.identifier.doi10.1080/21645515.2015.1114196
dc.identifier.urihttp://hdl.handle.net/10871/24353
dc.language.isoenen_GB
dc.publisherTaylor & Francisen_GB
dc.relation.urlhttp://www.tandfonline.com/doi/full/10.1080/21645515.2015.1114196en_GB
dc.rightsThis is the final version of the article. Available from Taylor & Francis via the DOI in this record.en_GB
dc.subjectapplication softwareen_GB
dc.subjectcommunity awarenessen_GB
dc.subjecte-healthen_GB
dc.subjectinvasiveen_GB
dc.subjectmobile appen_GB
dc.subjectpneumococcal diseaseen_GB
dc.subjectpneumococcusen_GB
dc.subjectpreventionen_GB
dc.titleDevelopment and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its preventionen_GB
dc.typeArticleen_GB
dc.date.available2016-11-09T13:58:35Z
dc.identifier.issn2164-5515
dc.descriptionPublisheden_GB
dc.identifier.eissn2164-554X
dc.identifier.journalHuman Vaccines and Immunotherapeuticsen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record